Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 29:9:199-205.
doi: 10.1016/j.dib.2016.08.039. eCollection 2016 Dec.

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma

Veit J Erpenbeck  1 , Todor A Popov  2 , David Miller  3 , Steven F Weinstein  4 , Sheldon Spector  5 , Baldur Magnusson  1 , Wande Osuntokun  6 , Paul Goldsmith  6 , Markus Weiss  1 , Jutta Beier  7
Affiliations

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma

Veit J Erpenbeck et al. Data Brief. .

Abstract

This article contains data on clinical endpoints (Peak Flow Expiratory Rate, fractional exhaled nitric oxide and total IgE serum levels) and plasma pharmacokinetic parameters concerning the use of the oral CRTh2 antagonist QAW039 (fevipiprant) in mild to moderate asthma patients. Information on experimental design and methods on how this data was obtained is also described. Further interpretation and discussion of this data can be found in the article "The oral CRTh2 antagonist QAW039 (fevipiprant): a phase II study in uncontrolled allergic asthma" (Erpenbeck et al., in press) [1].

PubMed Disclaimer

References

    1. V.J. Erpenbeck, Todor A. Popov, D. Miller, S.F. Weinstein, S. Spector, B. Magnusson, W. Osuntokun, P. Goldsmith, M.Weiss, J. Beier, The oral CRTh2 antagonist QAW039 (fevipiprant): Aa phase II study in uncontrolled allergic asthma, Pulm. Pharmcol. Ther. 39 (2016) 54–63 - PubMed
    1. ATS/ERS Task Force Standardisation of lung function testing. Eur. Respir. J. 2005;26:319–338. - PubMed

LinkOut - more resources